News

EACS and the European Centre for Disease Prevention and Control (ECDC) have released the report assessing HIV-related stigma and discrimination within healthcare settings in Europe and Central Asia following a European-wide survey. The report reveals significant gaps in knowledge on HIV transmission and prevention among healthcare workers. This lack of knowledge is associated with higher levels of stigma and discrimination against people living with HIV, hampering efforts to reach the Sustainable Development Goal of Ending AIDS by 2030.

The full report is available now! 

The next PentaTr@ining course kicks off on 16 September and will run for 12 weeks on our online training platform.

The programme is led by a group of international experts from the Penta-ID network, and Fungal Infections and EPMyN working groups. The course consists of interactive clinical cases with animations and voice narrations, discussion forums, video presentations, live Q&A webinars and a wealth of further reading educational resources. 

Moreover, the course is a unique networking opportunity for participants, with the chance to engage with a wide range of delegates and leading experts from around the globe.

Register now 

Management of HIV and Co-infections online course 

Now Available on the new EACS eAcademy!

Stay updated with the latest insights and guidelines on HIV and co-infections with the newly launched Management of HIV and Co-infections online course on the EACS eAcademy. This comprehensive course delves into cutting-edge research and best practices for treatment, prevention, testing, and monitoring activities. Tailor your learning experience by selecting from three engaging sections designed to fit your specific interests and needs.

For more information and registration, click here.

EACS has published the Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV. 

This EACS Interim Guidance has been developed to inform the use of statin therapy for the primary prevention of cardiovascular disease in people with HIV in Europe. The key recommendations were formed based on the best assessment of the evidence at the time of writing. As new evidence emerges, the guidance will be updated accordingly. 

Click here to see the full guidance and more information.

Professor Chloe Orkin based in the UK in the SHARE Collaborative for Health Equity ( https://shareresearch.org.uk/ ) is leading a study called CONSENSUS.

It is a survey for clinicians who are prescribing Cabotegravir and Rilipvirine as treatment for HIV. The aim of the survey is to understand how clinicians define virological failure and discontinuation in the context of CAB+RPV.

The survey will take about 5-8 min to complete.

Virological failure survey

24 April 2024

Join the 90-minute WAVE (Women Against Viruses in Europe) meeting on Wednesday, 24 April at 18:00 CEST with a focus on HIV and breastfeeding.

All participants will have the opportunity to join the discussion or ask questions in the chat.

Registration

20-27 May 2024 

European Testing Week is a campaign that encourages organisations and institutions — in community, health care and policy institutions — throughout Europe to unite for one week twice a year to increase testing efforts and promote awareness on the benefits of earlier hepatitis and HIV testing. This initiative has progressed since its start in 2013 and has grown to be a widely recognised European event with hundreds of organisations participating every year.

Participants volunteer their own time to organise their European Testing Week activities and create incredible displays of a united effort to increase testing awareness at all organisational levels.

There are a number of ways that organisations can help to increase access to HIV, hepatitis and STI testing, with activities such as: 

• Advocacy initiatives for voluntary, confidential and free HIV, hepatitis, and/or STI testing
• Awareness raising activities for key populations at higher risk
• HIV, hepatitis, and/or STI testing outreach activities for key populations
• Capacity building initiatives (e.g. training of medical students, healthcare staff)
• Policy meetings
• Engagement with opinion makers and the media

 Learn more

31 May - 1 June 2024

The 17th edition of the International Symposium on Neuropsychiatry & HIV will take place in Barcelona in a hybrid format on 31 May- 1 June 2024.  

This Symposium has a practical focus on the diagnosis and treatment of the psychiatric and neuropsychological aspects of people living with HIV.  

The Symposium will include several updated lectures on sleep disorders in people living with HIV, Neuropathogenesis of HIV and Stigma and discrimination.

More information